|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.880 EUR | +0.52% |
|
+0.52% | +12.79% |
| 05/05 | MEDICLIN Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04/05 | MEDICLIN Aktiengesellschaft Revises Earnings Guidance for the Year 2026 | CI |
| Market Cap | 19Cr 22Cr 18Cr 16Cr 31Cr 2.08TCr 31Cr 210.67Cr 82Cr 1.02TCr 82Cr 80Cr 3.52TCr | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 19Cr 22Cr 18Cr 16Cr 31Cr 2.08TCr 31Cr 210.67Cr 82Cr 1.02TCr 82Cr 80Cr 3.52TCr | EV / Sales 2026 * |
0.24x | EV / Sales 2027 * | 0.24x |
| Free-Float |
12.27% | Yield 2026 * |
1% | Yield 2027 * | 1% |
| 1 day | +0.52% | ||
| 1 week | +0.52% | ||
| Current month | -0.51% | ||
| 1 month | -3.96% | ||
| 3 months | +16.17% | ||
| 6 months | +8.99% | ||
| Current year | +12.79% |
| 1 week | 3.84 |  | 3.9 |
| 1 month | 3.84 | | 4.18 |
| Current year | 3.26 | | 4.18 |
| 1 year | 2.84 | | 4.18 |
| 3 years | 2.2 | | 4.18 |
| 5 years | 2.2 | | 4.18 |
| 10 years | 2.2 | | 6.76 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tino Marco Fritz
CEO | Chief Executive Officer | 49 | - |
Martin Buse
CMP | Compliance Officer | - | - |
Thomas Piefke
COO | Chief Operating Officer | - | 01/10/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Hans Hilpert
BRD | Director/Board Member | 60 | 01/01/2003 |
Michael Bock
BRD | Director/Board Member | 63 | 25/05/2005 |
| Director/Board Member | 63 | 20/09/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.52% | +0.52% | - | - | 22Cr | |
| -0.24% | -4.57% | +18.98% | +38.61% | 1.77TCr | |
| +2.27% | +3.51% | +17.56% | +75.47% | 1.34TCr | |
| +1.06% | +6.88% | -30.66% | -54.98% | 1.17TCr | |
| +5.00% | +5.06% | -10.57% | +58.54% | 1.06TCr | |
| +2.06% | +3.17% | +12.01% | +79.17% | 974.99Cr | |
| +2.03% | +6.35% | -0.99% | -27.57% | 963.15Cr | |
| -0.04% | +2.07% | +22.74% | +210.63% | 772.77Cr | |
| +1.21% | +2.46% | +14.17% | -22.19% | 704.19Cr | |
| +0.45% | -0.89% | -16.79% | - | 674.59Cr | |
| Average | +1.43% | +1.54% | +2.94% | +44.71% | 1.05TCr | |
| Weighted average by Cap. | +1.51% | +1.14% | +3.93% | +41.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 79Cr 90Cr 72Cr 67Cr 127.95Cr 8.58TCr 129.89Cr 868.81Cr 337.75Cr 4.22TCr 338.12Cr 330.86Cr 15TCr | 80Cr 92Cr 74Cr 69Cr 130.5Cr 8.75TCr 132.48Cr 886.18Cr 344.5Cr 4.3TCr 344.89Cr 337.48Cr 15TCr |
| Net income | 3.67Cr 4.19Cr 3.37Cr 3.14Cr 5.96Cr 399.31Cr 6.05Cr 40Cr 16Cr 196.28Cr 16Cr 15Cr 676.37Cr | 3.82Cr 4.37Cr 3.51Cr 3.27Cr 6.21Cr 416.01Cr 6.3Cr 42Cr 16Cr 204.49Cr 16Cr 16Cr 704.65Cr |
| Net Debt | - | - |
Employees
7,416
Calendar
30/07 -
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/26/03 | €3.880 | +0.52% | 0 |
| 02/26/02 | €3.860 | +0.52% | 0 |
| 01/26/01 | €3.840 | -1.54% | 0 |
| 30/26/30 | €3.900 | 0.00% | 200 |
| 29/26/29 | €3.900 | +1.04% | 90 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.020EUR
Average target price
7.300EUR
Spread / Average Target
+81.59%
Net sales - Rate of surprise
- Stock Market
- Stocks
- MED Stock
- MED Stock
Select your edition
All financial news and data tailored to specific country editions
